Skip to main content

Advertisement

Fig. 2 | Cancer Cell International

Fig. 2

From: Inhibition LC3B can increase chemosensitivity of ovarian cancer cells

Fig. 2

Knockdown LC3B in ovarian cancer cells enhance sensitive of tumor cell to cisplatin. ac Western blot and statistical analysis of LC3B, Atg7, MDR1 and EpCAM expression in ovarian cancer cells. **p < 0.01, ***p < 0.001. d Cell viability was assessed by CCK-8 in LC3B- group and control group. eg The level of cleaved-caspase 3, caspase 6 and caspase 9 expression in ovarian cancer cells was measured by western blotting assay and statistical analysis. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page